Search
for
Sort by
Research 31–60 of 157
- Dermatological adverse events with taxane chemotherapy
- Drug-Induced Skin, Nail and Hair Disorders
- Tinea Capitis: An Overview with Emphasis on Management
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Adverse Cutaneous Reactions to Antipsychotics
- Graft-versus-host disease
- Cutaneous manifestations of HIV infection other than Kaposi's sarcoma: Clinical and histologic aspects
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- TOXIC EPIDERMAL NECROLYSIS
- Adverse Cutaneous Reactions to Mood Stabilizers
- Adverse Cutaneous Reactions to Antidepressants
- CLINICAL AND LABORATORY EVALUATION OF AIDS TRICHOPATHY
- The Clinical Presentation of Systemic Lupus Erythematosus
- Tinea capitis in adult women masquerading as bacterial pyoderma
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Anticonvulsant-Induced Cutaneous Reactions
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Dermatologic Reactions to Targeted Therapy
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- COVID-19 infection leading to acute pustular dermatoses
- Drug eruptions in dermatology
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease